Edison, NJ, United States of America

Brenda T Boyhan

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brenda T Boyhan. Retrieved from https://idiyas.com/inventor/brenda-t-boyhan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brenda T Boyhan: Innovator in Pharmaceutical Processes

Introduction

Brenda T Boyhan is a notable inventor based in Edison, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug production. Her work has led to advancements that enhance the efficiency and safety of pharmaceutical manufacturing.

Latest Patents

Brenda T Boyhan holds a patent for a process that enables large-scale preparation of 2',3'-didehydro-3'-deoxythymidine (d4T) and its close analogs. This improved process is designed to yield d4T in high yield and purity, while avoiding hazardous reactions or reagents. The patent also incorporates several process improvements that are crucial for large-scale production, including a novel purification step that involves the isolation of a d4T.N-methylpyrrolidinone solvate.

Career Highlights

Brenda has been associated with Bristol-Myers Squibb Company, where she has applied her expertise in pharmaceutical processes. Her innovative approach has contributed to the company's reputation for developing safe and effective medications.

Collaborations

Brenda has worked alongside esteemed colleagues such as Paul M Skonezny and Emerich Eisenreich. Their collaborative efforts have furthered advancements in pharmaceutical research and development.

Conclusion

Brenda T Boyhan's contributions to the pharmaceutical industry exemplify the impact of innovation in drug production. Her patented processes not only enhance efficiency but also prioritize safety in pharmaceutical manufacturing.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…